首页> 外文期刊>Human Molecular Genetics >Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease
【24h】

Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease

机译:巴顿病小鼠模型中轴突和突触病理的分子相关性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Neuronal ceroid lipofuscinoses (NCLs; Batten disease) are collectively the most frequent autosomal-recessive neurodegenerative disease of childhood, but the underlying cellular and molecular mechanisms remain unclear. Several lines of evidence have highlighted the important role that non-somatic compartments of neurons (axons and synapses) play in the instigation and progression of NCL pathogenesis. Here, we report a progressive breakdown of axons and synapses in the brains of two different mouse models of NCL: Ppt1−/− model of infantile NCL and Cln6nclf model of variant late-infantile NCL. Synaptic pathology was evident in the thalamus and cortex of these mice, but occurred much earlier within the thalamus. Quantitative comparisons of expression levels for a subset of proteins previously implicated in regulation of axonal and synaptic vulnerability revealed changes in proteins involved with synaptic function/stability and cell-cycle regulation in both strains of NCL mice. Protein expression changes were present at pre/early-symptomatic stages, occurring in advance of morphologically detectable synaptic or axonal pathology and again displayed regional selectivity, occurring first within the thalamus and only later in the cortex. Although significant differences in individual protein expression profiles existed between the two NCL models studied, 2 of the 15 proteins examined (VDAC1 and Pttg1) displayed robust and significant changes at pre/early-symptomatic time-points in both models. Our study demonstrates that synapses and axons are important early pathological targets in the NCLs and has identified two proteins, VDAC1 and Pttg1, with the potential for use as in vivo biomarkers of pre/early-symptomatic axonal and synaptic vulnerability in the NCLs.
机译:神经元类固醇脂褐藻糖(NCLs; Batten疾病)共同是儿童期最常见的常染色体隐性神经退行性疾病,但其潜在的细胞和分子机制仍不清楚。几条证据强调了非体细胞神经元(轴突和突触)在NCL发病机制的激发和发展中的重要作用。在这里,我们报告了两种不同的NCL小鼠模型的大脑中轴突和突触的逐步分解:婴儿NCL的Ppt1 -/-模型和变体的Cln6 nclf 模型晚期婴儿NCL。在这些小鼠的丘脑和皮层中,突触病理很明显,但在丘脑中发生得较早。先前涉及轴突和突触脆弱性调节的一部分蛋白质的表达水平的定量比较揭示了两种NCL小鼠中与突触功能/稳定性和细胞周期调节有关的蛋白质变化。蛋白质表达变化出现在症状早期/症状早期,发生在形态学上可检测到的突触或轴突病理之前,并再次显示出区域选择性,首先在丘脑内发生,然后在皮层内发生。尽管在所研究的两个NCL模型之间个体蛋白质表达谱存在显着差异,但在这两个模型中,在15个蛋白质中有2个(VDAC1和Pttg1)在症状前/早期症状时间点表现出强劲而显着的变化。我们的研究表明,突触和轴突是NCLs中重要的早期病理学靶标,并且已鉴定出两种蛋白VDAC1和Pttg1,它们有可能用作NCLs中有症状/早期症状的轴突和突触脆弱性的体内生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号